EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Pharmacological approaches for colitis associated colorectal cancer: a survey in preclinical studies

Erfan Abdollahizad, Anna Meyfour

Cancer Treatment and Research Communications · 2026

DOI: 10.1016/j.ctarc.2026.101301 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Treatment and Research Communications, 2026. Verfasst von Erfan Abdollahizad und 1 weiteren Autor:innen. Beteiligte Einrichtung: Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Be…. Hauptthemen laut MEDLINE: Colitis-Associated Neoplasms, Colorectal Neoplasms, Colitis. Die Arbeit nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shahid Beheshti University of Medical Sciences, Research Institute for Gastroenterology and Liver Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colitis-associated colorectal cancer (CAC) is a severe complication of inflammatory bowel disease (IBD), characterized by a unique inflammation-driven pathogenesis that distinguishes it from sporadic colorectal cancer. Despite advances in diagnostics and therapeutic interventions for IBD, effective preventive pharmacological treatments for CAC remain a critical unmet need. Drug discovery through the design and synthesis of novel molecules consumes considerable time and expense, especially for CAC in which no single enzyme, receptor, or gene dominates. Alternative approaches involve drug repurposing and application of natural compounds. The concurrent administration of multiple existing agents, as part of combination therapy, alongside the implementation of novel drug delivery systems such as nanocarriers, presents feasible and practical approaches for discovering effective treatments for CAC. After highlighting key molecular mechanisms in CAC pathogenesis, this review comprehensively surveys applied drug discovery approaches for CAC in preclinical studies. Our review highlights the importance of early and long-term intervention to prevent CAC, primarily by inhibiting the COX-2, STAT3, and NF-κB pathways associated with inflammation. Promising advances in CAC therapy involve the use of natural compounds and repurposed drugs, often administered in combination or through nanocarriers. These strategies aim to enhance therapeutic efficacy while minimizing toxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis-Associated NeoplasmsColorectal NeoplasmsColitisHumansAnimalsDrug DiscoveryInflammatory Bowel DiseasesDrug Delivery Systems

Stichwörter der Autor:innen

Colitis associated cancerCombination therapyDrug discoveryInflammatory bowel diseaseNano-drug delivery systemsNatural molecule

Autor:innen und Institutionen

  • Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic addres…

Förderung

  • Shahid Beheshti University of Medical Sciences
  • Research Institute for Gastroenterology and Liver Diseases

Zitieren

APA

Abdollahizad, E., & Meyfour, A. (2026). Pharmacological approaches for colitis associated colorectal cancer: a survey in preclinical studies. Cancer Treatment and Research Communications. https://doi.org/10.1016/j.ctarc.2026.101301

Vancouver

Abdollahizad E, Meyfour A. Pharmacological approaches for colitis associated colorectal cancer: a survey in preclinical studies. Cancer Treatment and Research Communications. 2026. doi:10.1016/j.ctarc.2026.101301

BibTeX
@article{Abdollahizad2026,
  author = {Abdollahizad, Erfan and Meyfour, Anna},
  title = {Pharmacological approaches for colitis associated colorectal cancer: a survey in preclinical studies},
  journal = {Cancer Treatment and Research Communications},
  year = {2026},
  doi = {10.1016/j.ctarc.2026.101301}
}
Kostenlos starten →